Filing Flows › Veracyte (VCYT) › Free cash flow
Veracyte (VCYT) free cash flow by quarter
Veracyte's free cash flow was $37.9M in Q3 2026 (third quarter 2026), -12% from Q2 2026. Over the last 7 quarters it ranged from $3.5M (Q1 2025) to $48.8M (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $37.9M | -12% | -10% |
| Q2 2026 | $43.0M | +33% | +33% |
| Q1 2026 | $32.3M | -34% | +810% |
| Q4 2025 | $48.8M | +16% | — |
| Q3 2025 | $42.0M | +30% | — |
| Q2 2025 | $32.3M | +812% | — |
| Q1 2025 | $3.5M | — | — |
Q3 2026 at a glance
Veracyte, Q3 2026: revenue $152M (+15% year over year), operating margin 10.9%, net earnings $31.5M, operating cash flow $40.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Veracyte's free cash flow?
Veracyte's free cash flow was $37.9M in Q3 2026 (third quarter 2026), -12% from Q2 2026.
How has Veracyte's free cash flow changed?
Over the last 7 quarters it ranged from $3.5M (Q1 2025) to $48.8M (Q4 2025).